Skip to main content
Account

Peer review reports

From: Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway

Original Submission
30 Mar 2023 Submitted Original manuscript
7 Apr 2023 Reviewed Reviewer Report
11 May 2023 Author responded Author comments - Haiting Zhan
Resubmission - Version 2
11 May 2023 Submitted Manuscript version 2
Publishing
5 Jun 2023 Editorially accepted
10 Jul 2023 Article published 10.1186/s13019-023-02300-7

Learn about peer review

Back to article page

Navigation